Angel Martin
InvestorVice President at Frazier Life Sciences Β· Senior Associate at Frazier Healthcare Partners
San Diego
About
Angel Martin is a Vice President at Frazier Life Sciences, which she joined in 2021 to evaluate investment opportunities in the life sciences sector. She previously worked as an Investment Fellow with Vertex Ventures Healthcare and held roles as Director of Research and Venture Grants at Emerson Collective, Health and Research Director of the Friedreich Ataxia Research Alliance. She holds a Ph.D. in Pharmacology and Cancer Biology from Duke University and a B.A. from the University of Michigan, Ann Arbor.
Invests in
Biotech
Experience
- Frazier Life SciencesVice Presidentcurrent2021 β presentPalo Alto, California, United States
- Vertex Ventures HCHealthcare Investment Fellow2020San Francisco Bay Area
- Emerson CollectiveDirector, Research and Venture Grants, Health Team2019 β 2020Palo Alto, California
- Emerson CollectiveManager, Grants and Special Projects, Health Team2018 β 2019Palo Alto, CA
- Friedreich's Ataxia Research Alliance (FARA)Research Director2017 β 2018Downingtown, PA
- McKinsey & CompanyAdvanced Professional Degree Intern (Insight Healthcare)2017Greater Philadelphia
Education
- Duke UniversityDoctor of Philosophy (PhD), Pharmacology and Molecular Cancer Biology2012 β 2017
- Duke UniversityCertificate, Cellular and Molecular Biology2012 β 2017
- University of Michigan College of Literature, Science, and the ArtsBachelor of Arts (B.A.), Biochemistry2007 β 2012
Skills & more
+3 more
StatisticsMolecular CloningKeynoteLanguages Spanish
- Drug Discovery β Coursera
From Angel's professional profile.
Same school
Also attended Duke University412
+ 406 more
Also attended University of Michigan College of Literature, Science, and the Arts11
+ 5 more
Shared employers
Also worked at Frazier Life Sciences46
+ 40 more
Also worked at Vertex Ventures HC5
Also worked at Emerson Collective18
+ 12 more
Also worked at McKinsey & Company1,209
+ 1,203 more
Investments
Board seats
Alesta TherapeuticsV6 Therapeutics
Investor
Sonoma Biotherapeutics
Per the firm's website.























.jpg)






